Crystal structure analysis reveals conformational differences in ligand-binding pockets of tRNA ligase, suggesting new therapeutic strategies.
The tRNA ligase (TRL1) is a highly conserved multidomain protein that is the archetype of the recently characterized Rnl6 clade. This clade distinguishes itself through a distinct C-terminal domain, that sets it apart from other RNA ligase families (1)(1–3). TRL1 is an essential component of pre-tRNA splicing and the processing of the Ire1p (“Inositol-requiring enzyme 1″) dependent non-canonical splicing of the mRNA coding for HAC-1 (“Homologous to ATF/CREB1”), a transcription factor critical for the unfolded protein response (UPR) in the kingdom of fungi. Here we report the crystal structure of the N-terminal adenylyl transferase domain (LIG) from Candida glabrata (Nakaseomyces glabratus). The asymmetric unit contained two molecules in complex with non-covalently linked AMP, revealing conformational differences. In comparison to previous studies, we observe two distinct and partially overlapping ligand-binding pockets, implying new specific residues involved in ligand binding and recognition. These insights on TRL1’s ligand adaptability have important implications for the development of targeted therapies.
No takes yet. Share an insight, caveat, or question.
McEwen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: